Enabling Technologies Consortium (ETC) RFI/RFPs and third-party project proposals
Enabling Technologies Consortium (ETC) RFI/RFPs and third-party project proposals is a funding call from Enabling Technologies Consortium (16 pharma member companies) that has no fixed deadline (rolling). Funding: not stated in source data — see the official call. Eligibility: Open to the scientific community (academia/vendors) responding to RFI/RFPs or proposing projects; details per RFP.
- Funder
- Enabling Technologies Consortium (16 pharma member companies)
- Deadline
- Rolling / no fixed deadline
- Amount
- Not stated in source data — see call
- Region / eligibility
- International
- Career stage
- established / PI
- Fields
- pharma process, crystallization
- Reference
- —
- Official call
- Funder page (curated calendar) listing
Eligibility in plain language
Open to the scientific community (academia/vendors) responding to RFI/RFPs or proposing projects; details per RFP.
Who should apply
Medicinal chemists and pharma process / drug-development teams, crystal growth / crystallization researchers — best fit for PIs and research groups.
Summary from source
Pharma CMC consortium that funds third-party technology projects via RFI→RFP and accepts unsolicited project ideas. Industry-funded projects on pharma CMC tools (past ones: crystallizers, population balance modelling); a 2026 RFI 'Solubility Prediction of Multicomponent Crystals' was announced on ETC's LinkedIn – check website.